The impact of blood contamination on the proteome of cerebrospinal fluid.
about
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkersEffects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteomeProteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.Characterization of individual mouse cerebrospinal fluid proteomesRecent cerebrospinal fluid biomarker studies of Alzheimer's disease.Confounding factors influencing amyloid Beta concentration in cerebrospinal fluidMass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide.Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid.Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model.A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.Total protein is an effective loading control for cerebrospinal fluid western blotsApolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from miceCerebrospinal fluid biomarkers in primary headache disorders.Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometryQuantitative proteomics comparison of arachnoid cyst fluid and cerebrospinal fluid collected perioperatively from arachnoid cyst patients.Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.Discovering new bioactive neuropeptides in the striatum secretome using in vivo microdialysis and versatile proteomics.Proteomic strategies in multiple sclerosis and its animal modelsMass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research.Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.CXCL1 Triggers Caspase-3 Dependent Tau Cleavage in Long-Term Neuronal Cultures and in the Hippocampus of Aged Mice: Implications in Alzheimer's Disease.Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral SclerosisEstrogen and insulin transport through the blood-brain barrierCerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions.
P2860
Q28477629-1FD35374-87C0-4C2C-B712-DA67E8D9F92BQ28540483-18E291E3-9207-4F43-A064-804D567B4360Q30988577-B551DABA-6BA3-449F-9A8D-44EC1F41C0A4Q33481896-0F0EA103-69BF-4154-A75B-0B577A2BFB4EQ33536646-1F7F8B93-BE45-4F05-AA35-A34B72868F32Q33691896-54C3DC6E-C3C6-4EBF-8802-15B8919FEE22Q33709259-FB03FFA3-303F-4AE9-80FB-9878DF8BF275Q33766323-2DDDA716-A2F0-48B2-AB06-72471B233F3EQ34078408-F3EB0706-9E54-4C20-8791-6EA8CB254673Q34453057-3F819AE9-600C-4258-A817-A4F140E3114DQ34456110-D32FE488-AE45-437D-B5B1-FE9DCB3A2674Q34490428-3F04BCA6-BD8B-4EB4-99B5-B907F5149E4DQ35291150-2AB4247F-86B7-41D9-8A08-95BEC8879C32Q35966833-298FDE8D-5C1C-4FAF-BA23-1C177BD06E78Q36454486-C260CE9C-14BB-44E3-AB83-926B722B2E27Q36546364-6F652D80-048B-4C67-87C7-173D7CC9DB68Q36599253-2A9FD2F2-A756-4E4B-A579-A1458DCCCB05Q36811539-008F068A-A0AA-48B7-9074-8723EAB293DFQ36934178-736D2E1B-E846-4F91-B3FD-4FE0BEFEC615Q37210683-B7E168A2-FE45-44B9-844C-4C87C3B99DA4Q37347220-9852DCE0-5784-4DAA-8B02-0A4DF213BF3FQ37552845-92677E1D-40C6-4619-A4FF-CBE8E058C47CQ37818319-0B15F861-8E64-47CA-938E-88A351AE6053Q38037155-244FFA36-5E13-4CCD-B8E3-B106D4489352Q38113846-35AD6334-D941-4FED-B469-6D92DDC5E508Q38232016-862BC4A7-FBD9-423F-B1DA-27F9F3045E43Q38653383-81274EBA-7A0B-4D52-B01F-6BE35B903BF0Q40507089-DC304A4D-914A-4F00-9624-AA8902955EDEQ41401375-85169C77-F90F-41A9-8423-81523457F616Q41856273-EF3135F1-9D83-4303-BC3D-3392391F15D8Q47587631-9797F933-855A-4128-9FE3-087EA9D7F248Q47973239-1905C184-1C5D-455A-9C81-00570E0FA901Q48269484-7F755965-F50A-45A5-B5F0-B783E4056C56Q54963160-604E0C38-E813-44CF-8DE1-B524906340CE
P2860
The impact of blood contamination on the proteome of cerebrospinal fluid.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
The impact of blood contamination on the proteome of cerebrospinal fluid.
@ast
The impact of blood contamination on the proteome of cerebrospinal fluid.
@en
type
label
The impact of blood contamination on the proteome of cerebrospinal fluid.
@ast
The impact of blood contamination on the proteome of cerebrospinal fluid.
@en
prefLabel
The impact of blood contamination on the proteome of cerebrospinal fluid.
@ast
The impact of blood contamination on the proteome of cerebrospinal fluid.
@en
P2093
P356
P1433
P1476
The impact of blood contamination on the proteome of cerebrospinal fluid.
@en
P2093
Frank A Witzmann
Jin-Sam You
John E Hale
Michael D Knierman
Valentina Gelfanova
P2860
P304
P356
10.1002/PMIC.200400889
P577
2005-01-01T00:00:00Z